Keyword: Forma Therapeutics
Genentech veteran Frank Lee landed at Forma Therapeutics as it aimed to go from an early-stage company to one knocking on the door of approval.
NGM Bio gains a Genentech/Lilly vet as R&D chief; Forma nabs a Genentech commercial exec as CEO; and Nimbus builds out its biology and preclinical teams.
Forma Therapeutics has poached a Genentech senior VP, Frank Lee, to be its new CEO, effective March 27.
Gilead’s director of oncology clinical research jumps to Compugen, longtime Teva exec becomes Dr. Reddy's COO, Astellas names new ethics & compliance head.
Arpeggio’s technology combines new RNA sequencing technologies with machine learning to better understand drug candidates’ mechanism of action.
John Hohneker will join Anokion Therapeutics as president and CEO from Forma Therapeutics, where he served as R&D chief.